Post-approval studies (Phase 4)Study completedNCT02577861
What this trial is testing
Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency
Who this might be right for
Limbal Stem Cells Deficiency
Holostem s.r.l. 70